Issuance of Stock Acquisition Rights to Directors and Executive Officers
First written in FY2016-Q4. 10 of 14 entries say "Advanced", first in FY2017-Q4. Latest entry: FY2024.
- FY2024Expiration of paid stock acquisition rightsAnnual report
「2023 Paid stock acquisition rights End of previous consolidated fiscal year － Granted 6,100 Forfeited 6,100 Unvested balance －」
All 6,100 shares underlying the paid stock acquisition rights granted to executive officers in December 2023 were forfeited during the fiscal year, leaving no unvested balance. - FY2024-Q2AdvancedAnnual report
「Date of resolution 27 December 2023 Eligible recipients and number of recipients (people) Executive officers of the Company 1 Number of stock acquisition rights (the number of shares to be granted is to be adjusted using the following formula) ※ 61 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 6,100 (Note 1) Exercise period for the stock acquisition rights ※ From 1 December 2024 to 18 January 2026」
61 stock acquisition rights covering 6,100 common shares were issued to 1 executive officer. The exercise period is from 1 December 2024 to 18 January 2026. - FY2023-Q1AdvancedAnnual report
「Date of resolution 13 October 2022 Eligible recipients and number of recipients (people) Executive officers of the Company 6 Number of stock acquisition rights (the number of shares to be granted is to be adjusted using the following formula) ※ 873 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 87,300 (Note 1) Exercise period for the stock acquisition rights ※ From 1 December 2024 to 18 January 2026」
873 stock acquisition rights covering 87,300 common shares were issued to 6 executive officers. The exercise period is from 1 December 2024 to 18 January 2026. - FY2022-Q2AdvancedAnnual report
「Date of resolution 22 December 2021 Eligible recipients and number of recipients (people) Directors of the Company 6 Executive officers of the Company 17 Number of stock acquisition rights (the number of shares to be granted is to be adjusted using the following formula) ※ 4,745 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 474,500 Exercise period for the stock acquisition rights ※ From 1 December 2024 to 18 January 2026」
Paid stock options covering 474,500 common shares were issued to 6 directors and 17 executive officers in 2022. - FY2021Expiration of paid stock acquisition rightsAnnual report
「2019 Paid stock acquisition rights Before vesting (shares) End of previous consolidated fiscal year 1,760,000 Forfeited 1,760,000 Unvested balance －」
All 1,760,000 shares underlying the paid stock acquisition rights issued in 2019 were forfeited, leaving no unvested balance. - FY2021-Q2AdvancedAnnual report
「Date of resolution 23 December 2020 Categories and number of eligible recipients (people) Company directors 6 Company executive officers 12 Number of stock acquisition rights (the number of shares granted will be adjusted according to the following formula) (units) * 498 Class, details and number of shares underlying the stock acquisition rights (shares) * Common shares 49,800 (Note 1) Exercise period for the stock acquisition rights * From 8 January 2021 to 30 November 2050」
The Company issued stock acquisition rights covering 49,800 common shares to 6 directors and 12 executive officers. - FY2020AdvancedAnnual report
「19th Stock Options Categories and number of eligible recipients: 6 Company directors, 12 Company executive officers Class, details and number of shares underlying the stock acquisition rights: 36,300 common shares」
Under the 19th stock options, resolved on 24 June 2020 and granted on 9 July, 36,300 shares were granted to 6 directors and 12 executive officers. - FY2020RestatedAnnual report
「18th Stock Options Categories and number of eligible recipients: 6 Company directors, 13 Company executive officers Class, details and number of shares underlying the stock acquisition rights: 68,000 common shares」
The Company continues to disclose the stock option program for directors and executive officers and the terms of the options issued in 2019. - FY2019-Q4AdvancedAnnual report
「The stock acquisition rights issued during the second quarter were as follows. Date of resolution 19 June 2019 Categories and number of eligible recipients (people) Company directors 6 Company executive officers 13 Number of stock acquisition rights (units) * 71 Class, details and number of shares underlying the stock acquisition rights (shares) * Common shares 7,100 (Note 1) Exercise period for the stock acquisition rights * From 5 July 2019 to 31 May 2049」
The Company issued an additional 71 stock acquisition rights covering 7,100 shares to 6 directors and 13 executive officers. The exercise period runs from 5 July 2019 to 31 May 2049. - FY2019-Q3AdvancedAnnual report
「Categories and number of eligible recipients (people) Company directors 6 Company executive officers 14 Number of stock acquisition rights (units) * 1,760 Class, details and number of shares underlying the stock acquisition rights (shares) * Common shares 176,000 Exercise period for the stock acquisition rights * 1 December 2021 to 8 May 2023」
The allocation of the 2019 paid stock options, for which issuance was resolved in the previous fiscal year, to 6 directors and 14 executive officers was disclosed. The grant comprised 1,760 stock acquisition rights covering 176,000 shares. - FY2019AdvancedAnnual report
「At a meeting held on 24 April 2019, the Board of Directors resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the following stock acquisition rights to the Company's directors, excluding outside directors, and executive officers. Eligible recipients and number: Company directors and executive officers, 20 people Common shares: 176,000 shares Exercise period: 1 December 2021 to 8 May 2023」
The Company resolved to issue paid stock acquisition rights covering 176,000 common shares to 20 directors and executive officers. - FY2018-Q4AdvancedAnnual report
「The stock acquisition rights issued during the second quarter were as follows. Date of resolution 6 June 2018 Number of stock acquisition rights (units) 23 Number of shares underlying the stock acquisition rights (shares) 2,300 Exercise period 22 June 2018 to 31 May 2048」
The Company issued 23 stock acquisition rights for directors and executive officers, covering 2,300 shares. - FY2017-Q4AdvancedAnnual report
「Date of resolution 7 June 2017 Number of stock acquisition rights (units) 36 Number of shares underlying the stock acquisition rights (shares) 3,600 Exercise period 23 June 2017 to 31 May 2047」
The Company issued an additional 36 stock acquisition rights for directors and executive officers, covering 3,600 shares. - FY2016-Q4First statedAnnual report
「The stock acquisition rights issued during the second quarter were as follows. Date of resolution 8 June 2016 Number of stock acquisition rights (units) 32 Class of shares underlying the stock acquisition rights Common shares Number of shares underlying the stock acquisition rights (shares) 3,200 Amount payable upon exercise (yen) 1 Exercise period 24 June 2016 to 31 May 2046」
The Company issued 32 stock acquisition rights for directors and executive officers, covering 3,200 shares. The exercise period runs from 24 June 2016 to 31 May 2046.